期刊文献+

二膦酸盐对骨巨细胞瘤细胞的生长抑制和诱导凋亡作用 被引量:4

The experimental study of bisphosphonates inducing the expression of caspase-3 in the cells of bone giant cell tumor
原文传递
导出
摘要 目的观察二膦酸盐对骨巨细胞瘤细胞生长的影响。方法取10例手术切除的骨巨细胞瘤新鲜组织进行原代培养,待瘤细胞贴壁生长后分别给予5、25、50、100、200μmol/L阿仑膦酸钠、帕米膦酸二钠。作用一定时间后,用倒置相差显微镜观察细胞形态,MTT法检测细胞活性,末端酶标记法凋亡染色观察细胞凋亡情况,流式细胞术检测凋亡率和caspase-3表达。结果(1)二膦酸盐作用后,细胞正常形态消失,甚至发生崩解。(2)药物作用24h后,阿仑膦酸钠可以抑制细胞活性的2.79%±0.92%-31.17%±8.05%,帕米膦酸二钠为5.87%±1.94%-39.68%±9.26%;48h后,阿仑膦酸钠可以抑制细胞活性的8.68%±2.87%—46.88%±11.24%,帕米膦酸二钠为10.49%±3.26%~60.43%±13.64%;72h后,阿仑膦酸钠可以抑制细胞活性的11.13%±3.60%-49.94%±11.67%,帕米膦酸二钠为15.57%±5.86%~63.97%±16.42%。(3)药物作用48h后,阿仑膦酸钠和帕米膦酸二钠5μmol/L组的细胞凋亡率分别为16.25%±5.62%、20.48%±6.02%;50μmol/L组分别为37.20%±12.01%、42.39%+12.41%;200μmol/L组分别为47.53%+13.92%、54.67%+15.38%。(4)帕米膦酸二钠作用48h后,5、50、200μmol/L组瘤细胞的caspase-3活性分别为14.93%±5.04%、25.13%±7.60%、26.07%+7.49%,引起的细胞凋亡表现为时间和浓度依赖性。结论二膦酸盐可能成为治疗和预防骨巨细胞瘤复发的一个治疗方法。 Objective To evaluate the inhabitation of cell proliferation and apoptosis of giant cell tumor induced by bisphosphonates in vitro. Methods Ten tissue samples were harvested at the time of surgery from patients undergoing tumor resection. After the majority of tumor cells adhered to the culture flasks surface, Alendronate and pamidronate was used as test storage media at 5, 20, 50, 100, 200μM respectively. Cells viability was detected by MTT Assay after the tumor cells were cured with different concentration at different time periods. To detect tumor cells apoptosis with in situ TUNEL assay and flow cytometry. The active caspase-3 was also detected. Results After exposure to bisphosphonates, the cells exhibited the characteristic features of cell shrinkage, rounding and partial detachment, and demonstrated the lobulated appearance of apoptotic cells. It was much more prominent while the treating time prolonged or the concentration increased. Alendronate (5-200 μmol/L) treatment for 24 h, resulted in 2.79%±+0.92% to 31.17%± 8.05% decrease in cell viability, 8.68%±2.87% to 46.88%±11.24% for 48 h, and 11.13%±3.60% to 49.94%±11.67% for 72 h, respectively. Pamidronate (5-200μmol/L) treatment for 24 h, resulted in 5.87%±1.94% to 39.68%±9.26% decrease in cell viability, 10.49%±3.26% to 60.43%±13.64% for 48 h, and 15.57%±5.86% to 63.97%±16.42% for 72 h, respectively. A significant dose-dependent and time-dependent decrease in the number of viable cells was observed in the GCT cells. After bisphosphonate treatment for 48 hours, the mean cell population in apoptosis of alendronate and pamidronate was 16.25%±5.62% ,20.48%±6.02% at concentration 5μmol/L, 37.20%±12.01%, 42.39%±12.41% at concentration 50μmol/L, and 47.53%±13.92%, 54.67%±15.38% at concentration 200μmol/L respectively. In bisphosphonates-treated GCT cells, caspase-3 activation was observed. After treated by pamidronate for 48 h, caspase-3 expression was 14.93%±5.04%, 25.13%±7.60%, 26.07%±7.49% at 5, 50, 200μmol/L respectively. It was dose and time dependent response. Conclusion Bisphosphonates would be a new adjuvant treatment and prevention of recurrence besides the operation of giant cell tumor of bone.
出处 《中华骨科杂志》 CAS CSCD 北大核心 2007年第5期369-373,共5页 Chinese Journal of Orthopaedics
关键词 巨细胞瘤 二膦酸盐类 细胞凋亡 Giant cell tumor of bone Diphosphonates Apoptosis
  • 相关文献

参考文献17

  • 1黄承达.骨肿瘤及瘤样病变38959例统计分析[J].中华骨科杂志,1990,12:21-21.
  • 2Shipman CM, Rogers MJ, Apperley JF, et al. Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity. Br J Haematol, 1997, 98: 665-672.
  • 3Shipman CM, Croucher PI, Russell RG, et al. The bisphosphonate incadronate (YM175) causes apoptosis of human myeloma cells in vitro by inhibiting the mevalonate pathway. Cancer Res, 1998, 58:5294-5297.
  • 4Senaratne SG, Pirianov G, Mansi JL, et al. Bisphosphonates induce apoptosis in human breast cancer cell lines. Br J Cancer, 2000, 82: 1459-1468.
  • 5Hiraga T, Williams PJ, Mundy GR, et al. The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. Cancer Res, 2001, 61: 4418-4424.
  • 6Denoyelle C, Hong L, Vannier JP, et al. New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effects. Br J Cancer, 2003,88: 1631-1640.
  • 7Neudert M, Fischer C, Krempien B, et al. Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth. Int J Cancer, 2003, 107: 468-477.
  • 8Lee MV, Fong EM, Singer FR, et al. Bisphosphonate treatment inhibits the growth of prostate cancer cells. Cancer Res, 2001, 61:2602-2608.
  • 9Virtanen SS, Vaananen HK, Harkonen PL, et al. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway. Cancer Res, 2002, 62: 2708-2714.
  • 10Riebeling C, Forsea AM, Raisova M, et al. The bisphosphonate pamidronate induces apoptosis in human melanoma cells in vitro. Br J Cancer, 2002, 87: 366-371.

共引文献17

同被引文献47

  • 1施勋,滕理送,余新民,马胜林.唑来膦酸与帕米膦酸二钠治疗肺癌骨转移疼痛的对比研究[J].中华肿瘤防治杂志,2008,15(9):707-708. 被引量:10
  • 2范卫民,陈曦,李翔.抗生素骨水泥物理和力学性能及洗提特性的实验研究[J].中华骨科杂志,2003,23(6):361-364. 被引量:37
  • 3郭卫,杨毅,李晓,姬涛.四肢骨巨细胞瘤的外科治疗[J].中华骨科杂志,2007,27(3):177-182. 被引量:34
  • 4Oner F C, Verlaan J J, Verbout A J, et al. Cement augmentation techniques in traumatic thoracolumbar spine fractures[J]. Spine, 2006,31 (Suppl 11) : 89- 95.
  • 5Anselmetti G C, Manca A, Kanika K,et al. Temperature measurement during polymerization of bone cement in percutaneous vertebroplasty: an in vivo study in bumans[J]. Carcliovasc Intervent Radiol, 2009,32(3):491-498.
  • 6Urabe K,Naruse K, Hattori H, et al. In vitro comparison of elution characteristics of vancomycin from calcium phosphate cement and polymethylmethacrylate [J], J Orthop Sci, 2009, 14(6) : 784-793.
  • 7Young R C,Ozols R F,Myers C E,et al. The anthracycline antineoplastic rugs[J]. N Engl J Med,1981,305(3) :139-153.
  • 8Shinsako K,Okui Y, Mastsuda Y, et al. Effects of bead size and polymerization in PMMA hone cement on vancomycin release[J]. Biomed Master Enq,2008,18(6) :377-385.
  • 9Drognitz O,Thorn D,Kruger T,et al. Release of vancomycin and teicoplanin f rom a plasticized and resorbable gelatin sponge: in vitro investigation of a new antibiotic delivery system with glycopeptides [J]. Infection,2006,34(1) :29-34.
  • 10Bertazzoni Minelli E, Caveiari C, Benini A. Release of antibiotics from polymethylmethacrylate cement[J]. Chemotherapy, 2002, 14 (5) :492-500.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部